Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Phillip M. Schneider currently holds 40,000 shares of ARS Pharmaceuticals, Inc. (SPRY), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Phillip M. Schneider has been a net seller of SPRY stock. They have purchased $105.3K and sold $2.5M worth of shares.
Phillip M. Schneider's most recent insider trade was on Dec 2, 2024, when they sold 12,500 shares at $0.00 per share.
Phillip M. Schneider serves as Executive at ARS Pharmaceuticals, Inc. (SPRY). They have executed 46 insider transactions totaling $2.6M over their tenure at the company.
Phillip M. Schneider holds the position of Executive at ARS Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Phillip M. Schneider has shown a selling trading pattern, with $105.3K in total purchases and $2.5M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Phillip M. Schneider was on Feb 14, 2012, when they sold $1.4M worth of GPRO shares. This transaction involved 20,000 shares at $70.00 per share.
Phillip M. Schneider currently owns 40,000 shares of ARS Pharmaceuticals, Inc. (SPRY), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Phillip M. Schneider's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Phillip M. Schneider has 46 Form 4 filings on record as an insider at ARS Pharmaceuticals, Inc..
Set alerts for Phillip M. Schneider and 40,000+ other insiders.